Roche Receives CE Mark for Alzheimer’s Disease Blood Test
Roche received the CE mark for its Elecsys pTau217 blood test, an assay designed to detect Alzheimer’s disease…
Roche’s Elecsys® pTau181 becomes the only FDA-cleared blood test for use in primary care to rule out Alzheimer’s-related amyloid pathology
Rules out Alzheimer’s pathology in early stages to enhance diagnostic pathway efficiency Provides new opportunity to broaden access…